Eradication of Helicobacter pylori may improve dyspepsia in the elderly for the long term

BMC Gastroenterol. 2021 Nov 25;21(1):445. doi: 10.1186/s12876-021-02027-6.

Abstract

Background: Therapy for eradication of Helicobacter pylori (H. pylori) improves symptoms of H. pylori-associated dyspepsia (HPD), but the effects of eradication in elderly patients are unclear. The aim of our study was to investigate dyspepsia symptoms and long-term effects of eradication in elderly patients.

Methods: This retrospective study included 496 patients who received H. pylori eradication therapy. The patients were divided into a group of elderly patients (group E: ≧ 65 years old) and a group of non-elderly patients (group N: < 65 years old). Abdominal symptoms were evaluated using a questionnaire about abdominal symptoms before eradication and after eradication (1-2 months and more than one year). Dyspepsia was defined as a score of 4 points or more for at least one of 4 items (postprandial fullness, early satiety, epigastric pain, and hunger pain). Improvement of symptoms was defined on the basis of changes in Global Overall Systems scores.

Results: There were no differences in abdominal symptoms before eradication between the two groups. Successful eradication improved symptoms in patients with dyspepsia within 2 months (in 75.6% (56/74) of the patients in group N and in 64.5% (20/31) of the patients in group E). The questionnaire showed that 80% (32/40) of the patients in group N and 60% (12/20) of the patients in group E had long-term relief of dyspepsia. The scores for abdominal symptoms in group E continued to improve for a mean period of 54.8 months after eradication.

Conclusions: Eradication of H. pylori age-independently improved dyspepsia symptoms for the long term.

Keywords: Dyspepsia; Eradication therapy; Helicobacter pylori; The elderly.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Dyspepsia* / drug therapy
  • Helicobacter Infections* / complications
  • Helicobacter Infections* / drug therapy
  • Helicobacter pylori*
  • Humans
  • Middle Aged
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents